Source:http://linkedlifedata.com/resource/pubmed/id/12356272
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2002-10-1
|
pubmed:abstractText |
We have recently succeeded in preparing insulin-loaded microcapsules that release the insulin in a strictly controlled manner with little initial rapid release in-vitro or in-vivo. We show here the superiority of the best formulation prepared with co-poly(D,L-lactic/glycolic) acids (PLGA) (mean MW 5800, L/G ratio 50:50) with a main diameter of 15 approximately 30 microm in-vivo. When 3.2 % insulin-loaded PLGA microcapsules were subcutaneously given as a single dose to streptozotocin-induced hyperglycaemic rats (250 U kg(-1)), plasma insulin levels gradually increased and constant levels (30.3-94.1 microU mL(-1)) were sustained. Rats receiving the formulation once a week showed not only steady plasma insulin levels, but also gained weight at a similar speed to normal rats. Meanwhile, daily treatment with Humulin U (25 U kg(-1)) caused a transient high insulin level (2723.9 microU mL(-1) at 1 h) in plasma, but the body weight of the rats was little changed. A pharmacological study in female Cynomolgus monkeys also revealed that the microcapsular formulation provided a flat release of insulin for longer periods and showed no immunogenic activity. In the near future, therefore, this insulin formulation could become very beneficial as a provider of basal insulin levels for insulin-dependent diabetic patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-3573
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1189-94
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12356272-Animals,
pubmed-meshheading:12356272-Body Weight,
pubmed-meshheading:12356272-Capsules,
pubmed-meshheading:12356272-Chemistry, Pharmaceutical,
pubmed-meshheading:12356272-Delayed-Action Preparations,
pubmed-meshheading:12356272-Diabetes Mellitus, Experimental,
pubmed-meshheading:12356272-Female,
pubmed-meshheading:12356272-Hyperglycemia,
pubmed-meshheading:12356272-Insulin,
pubmed-meshheading:12356272-Macaca fascicularis,
pubmed-meshheading:12356272-Male,
pubmed-meshheading:12356272-Rats,
pubmed-meshheading:12356272-Rats, Wistar
|
pubmed:year |
2002
|
pubmed:articleTitle |
A novel insulin formulation can keep providing steady levels of insulin for much longer periods in-vivo.
|
pubmed:affiliation |
Institute of Medical Science, St Marianna University School of Medicine, Kawasaki, Japan. m2take@marianna-u.ac.jp
|
pubmed:publicationType |
Journal Article
|